SXTP - צמיחת הכנסות שנתית ב-12 החודשים האחרונים 60degreespharma.com

לוגו גרפי של 60degreespharma.com (SXTP)

The year-over-year sales volume growth trajectory for the trailing year on GURU.Markets helps assess the efficiency of the fabless model at 60 Degrees Pharmaceuticals (SXTP), where testing and pill production are outsourced to third-party contractors. The business generates revenue from supplying antimalarial drugs to the military and residents of tropical regions. Collaboration with proven vendors ensures scaling without production disruptions, and the current metric is recorded at 24.60.

צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים 60degreespharma.com (SXTP): לתקופה 23.11.2025 - 18.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת 60 Degrees Pharmaceuticals, Inc. (SXTP)

- מחיר נוכחי ושווי מניות חזוי:
הערכת שווי פונדמנטלית של החברה:60degreespharma.com
מוצר ממותג של 60degreespharma.com

For 60 Degrees Pharmaceuticals (SXTP), which develops anti-malarial drugs through US government contracts, the year-over-year revenue growth trend on a rolling basis reflects the efficiency of commercializing scientific research. This indicator calculates TTM sales dynamics, allowing investors to differentiate business expansion from capital stagnation by assessing current income growth rates relative to the same period last year.